MARC details
| 000 -LEADER |
|---|
| fixed length control field |
08532cam a22003495a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
19203263 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20181103113001.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
160802t2017 nyu frb 001 0 eng d |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2016035246 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781259587481 (hardcover) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1259587487 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(DNLM)101689751 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Language of cataloging |
eng |
| Transcribing agency |
DLC |
| Modifying agency |
DLC |
| -- |
EG-ScBUE |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.58 |
| Item number |
PHA |
| Edition number |
22 |
| 130 0# - MAIN ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Pharmacotherapy (New York) |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Pharmacotherapy : |
| Remainder of title |
a pathophysiologic approach / |
| Statement of responsibility, etc |
editors, Joseph T. DiPiro... [et al.] |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
10th ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
New York : |
| Name of publisher, distributor, etc |
McGraw-Hill Education, |
| Date of publication, distribution, etc |
c.2017. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxxiii, 2474 p. : |
| Dimensions |
ill. (col.) ; |
| Other physical details |
30 cm. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Section 1: Foundation Issues --<br/>Chapter e1: Health Literacy and Medication Use --<br/>Chapter e2: Cultural Competency --<br/>Chapter e3: Medication Safety Principles and Practices --<br/>Chapter e4: Clinical Pharmacokinetics and Pharmacodynamics --<br/>Chapter e5: Pharmacogenetics --<br/>Chapter e6: Pediatrics --<br/>Chapter e7: Geriatrics --<br/>Chapter e8: Palliative Care --<br/>Chapter e9: Clinical Toxicology --<br/>Chapter e10: Clinical Management of Potential Bioterrorism-related Conditions --<br/>Section 2: Cardiovascular Disorders --<br/>Chapter e11: Cardiovascular Testing --<br/>Chapter 12: Cardiac Arrest --<br/>Chapter 13: Hypertension --<br/>Chapter 14: Chronic Heart Failure --<br/>Chapter 15: Acute Decompensated Heart Failure --<br/>Chapter 16: Stable Ischemic Heart Disease --<br/>Chapter 17: Acute Coronary Syndromes --<br/>Chapter 18: The Arrhythmias --<br/>Chapter 19: Venous Thromboembolism --<br/>Chapter 20: Stroke --<br/>Chapter 21: Dyslipidemia --<br/>Chapter e22: Peripheral Arterial Disease --<br/>Chapter 23: Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock --<br/>Chapter 24: Hypovolemic Shock --<br/>Chapter e25: Introduction to Pulmonary Function Testing --<br/>Section 3: Respiratory Disorders --<br/>Chapter 26: Asthma --<br/>Chapter 27: Chronic Obstructive Pulmonary Disease --<br/>Chapter 28: Pulmonary Arterial Hypertension --<br/>Chapter 29: Cystic Fibrosis --<br/>Chapter e30: Drug-Induced Pulmonary Diseases --<br/>Section 4: Gastrointestinal Disorders --<br/>Chapter e31: Evaluation of the Gastrointestinal Tract --<br/>Chapter 32: Gastroesophageal Reflux Disease --<br/>Chapter 33: Peptic Ulcer Disease and Related Disorders --<br/>Chapter 34: Inflammatory Bowel Disease --<br/>Chapter 35: Nausea and Vomiting --<br/>Chapter 36: Diarrhea, Constipation, and Irritable Bowel Syndrome --<br/>Chapter 37: Portal Hypertension and Cirrhosis --<br/>Chapter e38: Drug-Induced Liver Disease --<br/>Chapter 39: Pancreatitis --<br/>Chapter 40: Viral Hepatitis --<br/>Chapter 41: Celiac Disease --<br/>Section 5: Renal Disorders --<br/>Chapter e42: Evaluation of Kidney Function --<br/>Chapter 43: Acute Kidney Injury --<br/>Chapter 44: Chronic Kidney Disease --<br/>Chapter 45: Hemodialysis and Peritoneal Dialysis --<br/>Chapter 46: Drug-Induced Kidney Disease --<br/>Chapter 47: Glomerulonephritis --<br/>Chapter 48: Drug Therapy Individualization for Patients with Chronic Kidney Disease --<br/>Chapter 49: Disorders of Sodium and Water Homeostasis --<br/>Chapter 50: Disorders of Calcium and Phosphorus Homeostasis --<br/>Chapter 51: Disorders of Potassium and Magnesium Homeostasis --<br/>Chapter 52: Acid-Base Disorders --<br/>Section 6: Neurologic Disorders --<br/>Chapter e53: Evaluation of Neurologic Illness --<br/>Chapter 54: Alzheimer Disease --<br/>Chapter 55: Multiple Sclerosis --<br/>Chapter 56: Epilepsy --<br/>Chapter 57: Status Epilepticus --<br/>Chapter 58: Acute Management of the Brain Injury Patient --<br/>Chapter 59: Parkinson Disease --<br/>Chapter 60: Pain Management --<br/>Chapter 61: Headache Disorders --<br/>Section 7: Psychiatric Disorders --<br/>Chapter e62: Assessment of Psychiatric Disorders --<br/>Chapter 63: Attention Deficit/Hyperactivity Disorder --<br/>Chapter 64: Eating Disorders --<br/>Chapter 65: Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens --<br/>Chapter 66: Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine --<br/>Chapter 67: Schizophrenia --<br/>Chapter 68: Major Depressive Disorder --<br/>Chapter 69: Bipolar Disorder --<br/>Chapter 70: Anxiety Disorders: Generalized Anxiety, Panic, and Social Anxiety Disorders. Chapter 71: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder --<br/>Chapter 72: Sleep-Wake Disorders --<br/>Chapter 73: Disorders Associated with Intellectual Disabilities --<br/>Section 8: Endocrinologic Disorders --<br/>Chapter 74: Diabetes Mellitus --<br/>Chapter 75: Thyroid Disorders --<br/>Chapter 76: Adrenal Gland Disorders --<br/>Chapter e77: Pituitary Gland Disorders --<br/>Section 9: Gynecologic and Obstetric Disorders --<br/>Chapter 78: Pregnancy and Lactation: Therapeutic Considerations --<br/>Chapter 79: Contraception --<br/>Chapter 80: Menstruation-Related Disorders --<br/>Chapter 81: Endometriosis --<br/>Chapter 82: Hormone Therapy in Women --<br/>Section 10: Urologic Disorders --<br/>Chapter 83: Erectile Dysfunction --<br/>Chapter 84: Benign Prostatic Hyperplasia --<br/>Chapter 85: Urinary Incontinence --<br/>Section 11: Immunologic Disorders --<br/>Chapter e86: Function and Evaluation of the Immune System --<br/>Chapter 87: Systemic Lupus Erythematosus --<br/>Chapter e88: Drug Allergy --<br/>Chapter 89: Solid-Organ Transplantation --<br/>Section 12: Rheumatologic Disorders --<br/>Chapter 90: Osteoarthritis --<br/>Chapter 91: Rheumatoid Arthritis --<br/>Chapter 92: Osteoporosis and Osteomalacia --<br/>Chapter 93: Gout and Hyperuricemia --<br/>Section 13: Ophthalmic and Otolaryngological Disorders --<br/>Chapter 94: Glaucoma --<br/>Chapter 95: Allergic Rhinitis --<br/>Section 14: Dermatologic Disorders --<br/>Chapter 96: Acne Vulgaris --<br/>Chapter 97: Psoriasis --<br/>Chapter 98: Atopic Dermatitis --<br/>Chapter e99: Dermatologic Drug Reactions and Common Skin Conditions --<br/>Section 15: Hematologic Disorders --<br/>Chapter 100: Anemias --<br/>Chapter 101: Coagulation Disorders --<br/>Chapter 102: Sickle Cell Disease --<br/>Chapter e103: Drug-Induced Hematologic Disorders --<br/>Section 16: Infectious Diseases --<br/>Chapter e104: Laboratory Tests to Direct Antimicrobial Pharmacotherapy --<br/>Chapter 105: Antimicrobial Regimen Selection --<br/>Chapter 106: Central Nervous System Infections --<br/>Chapter 107: Lower Respiratory Tract Infections --<br/>Chapter 108: Upper Respiratory Tract Infections --<br/>Chapter 109: Influenza --<br/>Chapter 110: Skin and Soft-Tissue Infections --<br/>Chapter 111: Infective Endocarditis --<br/>Chapter 112: Tuberculosis --<br/>Chapter 113: Gastrointestinal Infections and Enterotoxigenic Poisonings --<br/>Chapter 114: Intra-Abdominal Infections --<br/>Chapter 116: Urinary Tract Infections and Prostatitis --<br/>Chapter e115: Parasitic Diseases --<br/>Chapter 117: Sexually Transmitted Diseases --<br/>Chapter 118: Bone and Joint Infections --<br/>Chapter 119: Sepsis and Septic Shock --<br/>Chapter 120: Superficial Fungal Infections --<br/>Chapter 121: Invasive Fungal Infections --<br/>Chapter 122: Infections in Immunocompromised Patients --<br/>Chapter 123: Antimicrobial Prophylaxis in Surgery --<br/>Chapter e124: Travel Health --<br/>Chapter 125: Vaccines and Immunoglobulins --<br/>Chapter 126: Human Immunodeficiency Virus Infection --<br/>Section 17: Oncologic Disorders --<br/>Chapter 127: Cancer Treatment and Chemotherapy --<br/>Chapter 128: Breast Cancer --<br/>Chapter 129: Lung Cancer --<br/>Chapter 130: Colorectal Cancer --<br/>Chapter 131: Prostate Cancer --<br/>Chapter 132: Lymphomas --<br/>Chapter 133: Ovarian Cancer --<br/>Chapter 134: Acute Leukemias --<br/>Chapter 135: Chronic Leukemias --<br/>Chapter 136: Multiple Myeloma --<br/>Chapter e137: Myelodysplastic Syndromes --<br/>Chapter e138: Renal Cell Carcinoma --<br/>Chapter 139: Melanoma --<br/>Chapter 140: Hematopoietic Stem Cell Transplantation --<br/>Section 18: Nutritional Disorders --<br/>Chapter 141: Assessment of Nutrition Status and Nutrition Requirements --<br/>Chapter 142: Parenteral Nutrition --<br/>Chapter 143: Enteral Nutrition --<br/>Chapter 144: Obesity. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Focuses on how to achieve optimal patient outcomes through evidence-based medication therapy. This book is written to help readers advance the quality of patient care through evidence-based medication therapy derived from sound pharmacotherapeutic principles. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Therapy. |
| Source of heading or term |
BUEsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Chemotherapy. |
| Source of heading or term |
BUEsh |
| 651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
|---|
| Source of heading or term |
BUEsh |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Resource For college |
Pharmacy |
| Arrived date list |
November2018 |
| 655 ## - INDEX TERM--GENRE/FORM |
|---|
| Form subdivision |
Text book |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
DiPiro, Joseph T., |
| Relator term |
editor. |
| 9 (RLIN) |
36680 |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Contributor biographical information |
| Uniform Resource Identifier |
<a href="https://www.loc.gov/catdir/enhancements/fy1618/2016035246-b.html">https://www.loc.gov/catdir/enhancements/fy1618/2016035246-b.html</a> |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Publisher description |
| Uniform Resource Identifier |
<a href="https://www.loc.gov/catdir/enhancements/fy1618/2016035246-d.html">https://www.loc.gov/catdir/enhancements/fy1618/2016035246-d.html</a> |
| 952 ## - LOCATION AND ITEM INFORMATION (KOHA) |
|---|
| -- |
2018-11-03 |
| 952 ## - LOCATION AND ITEM INFORMATION (KOHA) |
|---|
| -- |
2018-11-03 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |